Telehealth booms as demand for GLP-1s surges and questions mount about safety, oversight

By: Lauren Sausser, KFF Health News, Maia Rosenfeld, KFF Health News

Outlets: Alaska Beacon

Published: June 2, 2026

Words: 3,223

Last Updated: 3 weeks, 3 days ago

Body Text Preview

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said.

The 31-year-old compliance consultant from Hendersonville, Tennessee, said she couldn’t stop vomiting.

“Sunday morning, it all hits,” McClain recalled, as she described what happened that weekend in January. “I can’t keep anything down.”

McClain said she thought the dosage the telehealth company had prescribed …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us